-
Immunotherapy for Early-stage Gastric Cancer
‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.
by Laura Gesualdi Gilmore
-
July 3: The Week in Cancer News
Uterine cancer diagnoses expected to climb in the next 25 years, and some disposable e-cigarettes emit more carcinogens than traditional cigarettes.
by Thomas Celona
-
Physical Activity Linked to Lower Colon Cancer Recurrence
Participating in a structured exercise program after treatment was associated with a reduced risk of recurrence in people who had colon cancer.
by Sandra Gordon
-
June 27: The Week in Cancer News
Low-dose aspirin reduces cancer risk for people with Lynch syndrome, and breast cancer survivors may have lower risk for Alzheimer’s than the general public.
by Thomas Celona
-
Gaps in Survivorship Care Leave Unmet Needs After Cancer Treatment
A survey of head and neck cancer survivors reveals that many are not getting adequate survivorship care and may not even know it is available.
by Cameron Walker
-
June 20: The Week in Cancer News
Surgery to remove fallopian tubes can lower ovarian cancer risk, and NIH staff cuts lead to delays for patients with no other treatment options.
by Eric Fitzsimmons
-
June 13: The Week in Cancer News
Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.
by Marci A. Landsmann
-
Improving Communication for Deaf Cancer Patients
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
-
June 6: The Week in Cancer News
A blood test can detect breast cancer drug resistance, and a combination treatment improves outcomes in colorectal cancer.
by Kevin McLaughlin
-
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?
Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona